Edition:
United States

Vetoquinol SA (VETO.PA)

VETO.PA on Paris Stock Exchange

47.05EUR
10:27am EST
Change (% chg)

€-0.74 (-1.55%)
Prev Close
€47.79
Open
€47.74
Day's High
€47.84
Day's Low
€47.00
Volume
3,079
Avg. Vol
2,414
52-wk High
€49.50
52-wk Low
€33.04

Latest Key Developments (Source: Significant Developments)

Vetoquinol H1 net income group share up at 13.5 million euros
Thursday, 28 Jul 2016 11:45am EDT 

Vetoquinol SA : H1 net income group share 13.5 million euros ($14.95 million) versus 12.4 million euros year ago . H1 revenue 172.2 million euros, up 3.0 percent .H1 EBITDA 27.4 million euros, up 20.2 percent.  Full Article

Vetoquinol will propose a dividend of EUR 0.41 per share
Monday, 21 Mar 2016 12:45pm EDT 

Vetoquinol SA:Will propose a dividend of EUR 0.41 per share.  Full Article

Vetoquinol forms Japanese JV with Nippon Zenyaku Kogyo
Thursday, 3 Dec 2015 02:40am EST 

Vetoquinol SA:Vetoquinol and Nippon Zenyaku Kogyo Co. Ltd. sign joint-venture agreement in Japan.JV Vetoquinol-Zenoaq K.K. is expected to start its operations in January 2016.  Full Article

Vetoquinol SA submits FY 2014 draft dividend of 0.37 euros per share
Monday, 23 Mar 2015 01:18pm EDT 

Vetoquinol SA:Submits FY 2014 draft dividend of 0.37 euros per share.  Full Article

Vetoquinol and Orion Pharma Animal Health enters into distribution collaboration
Thursday, 5 Feb 2015 02:00am EST 

Vetoquinol SA and Orion Pharma Animal Health:Announces their collaboration regarding the distribution of Dexdomitor, Antisedan, Domitor and Domosedan.Vétoquinol becomes distributor in selected European countries of these Orion Sedative products.The collaboration between the companies is effective as of Jan. 1 and Vétoquinol is responsible for marketing the Orion sedatives range to customers in United Kingdom, Germany, France, Ireland, The Netherlands, Belgium, Luxembourg and Italy.  Full Article

BRIEF-Vetoquinol Q3 revenue rises to 85.3 million euros

* Q3 revenue EUR 85.3 million ($93.78 million) versus EUR 84.6 million year ago